Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute Myeloid Leukemia”
Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine and Venetoclax in Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03041688. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03616470. IPD Sharing: Not stated. Countries: 9. Publications: 0.
STAT Inhibitor OPB-111077, Decitabine and Venetoclax in Treating Patients With Acute Myeloid Leukemia That Is Refractory, Relapsed or Newly Diagnosed and Ineligible for Intensive Chemotherapy
ClinicalTrials.gov study NCT03063944. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PET Tracer Based FDG Signal for Predicting Prognosis in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05919199. IPD Sharing: NO. Countries: 1. Publications: 0.
Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT06802315. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03330821. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
ClinicalTrials.gov study NCT05554406. IPD Sharing: YES. Countries: 3. Publications: 0.
The Use of Decitabine as Induction Therapy for Acute Myeloid Leukemia With Complex and/or Monosomal Karyotype
ClinicalTrials.gov study NCT03080766. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Evaluate the STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05947344. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Venetoclax in Combination With Decitabine in Subjects With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03844815. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Continuous Infusion Chemotherapy (CI-CLAM) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms
ClinicalTrials.gov study NCT04196010. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of KHK2823 in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02181699. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants of Any Age With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04813263. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Maintenance Therapy in Acute Myeloid Leukemia (AML) Patients
ClinicalTrials.gov study NCT00957385. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT07008638. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06532058. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00512083. IPD Sharing: Not stated. Countries: 2. Publications: 0.
UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05731219. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04777916. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers
ClinicalTrials.gov study NCT00899795. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.